Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma

Clinical trial NCT03908372 · UNKNOWN

Trial details

NCT number: NCT03908372
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stage II, III Nasopharyngeal Squamous Cell Carcinoma Induction Chemotheray Concurrent Chemoradiotherapy Reduce Treatment Intensity

Start date: 2019-06-15
Primary completion: 2021-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.